TY - CONF T1 - Evaluation of the molecular mechanisms for the sequence-dependent, synergistic anti-tumour effects of doxorubicin and zoledronic acid in breast cancer. JO - CANCER RESEARCH PY - 2009/01/15 AU - Ottewell PD AU - Leftey DV AU - Coleman RE AU - Holen I ED - VL - 69 IS - 2 SP - 200S EP - 201S Y2 - 2025/05/22 ER -